Literature DB >> 19252512

Available therapeutic options following failure of a first anti-TNF agent.

Alan J Silman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252512     DOI: 10.1038/ncprheum1028

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


× No keyword cloud information.
  1 in total

1.  Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug.

Authors:  K L Hyrich; M Lunt; W G Dixon; K D Watson; D P M Symmons
Journal:  Rheumatology (Oxford)       Date:  2008-04-17       Impact factor: 7.580

  1 in total
  1 in total

1.  A Dual Target-directed Agent against Interleukin-6 Receptor and Tumor Necrosis Factor α ameliorates experimental arthritis.

Authors:  Youngkyun Kim; Hyoju Yi; Hyerin Jung; Yeri Alice Rim; Narae Park; Juryun Kim; Seung Min Jung; Sung-Hwan Park; Young Woo Park; Ji Hyeon Ju
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.